Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2014 1
2015 3
2016 8
2017 11
2018 18
2019 27
2020 31
2021 4
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 33376101

98 results
Results by year
Filters applied: . Clear all
Page 1
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury.
Zhao M, Sun S, Huang Z, Wang T, Tang H. Zhao M, et al. Clin J Am Soc Nephrol. 2020 Dec 31;16(1):70-78. doi: 10.2215/CJN.11220720. Epub 2020 Dec 29. Clin J Am Soc Nephrol. 2020. PMID: 33376101
Cardiovascular efficacy and safety of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a systematic review and network meta-analysis.
Hussein H, Zaccardi F, Khunti K, Seidu S, Davies MJ, Gray LJ. Hussein H, et al. Diabet Med. 2019 Apr;36(4):444-452. doi: 10.1111/dme.13898. Epub 2019 Jan 30. Diabet Med. 2019. PMID: 30653708
How Do SGLT2 (Sodium-Glucose Cotransporter 2) Inhibitors and GLP-1 (Glucagon-Like Peptide-1) Receptor Agonists Reduce Cardiovascular Outcomes?: Completed and Ongoing Mechanistic Trials.
Lee MMY, Petrie MC, McMurray JJV, Sattar N. Lee MMY, et al. Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):506-522. doi: 10.1161/ATVBAHA.119.311904. Epub 2020 Jan 30. Arterioscler Thromb Vasc Biol. 2020. PMID: 31996025 Review.
Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.
Zheng SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, Francis D, Oliver N, Meeran K. Zheng SL, et al. JAMA. 2018 Apr 17;319(15):1580-1591. doi: 10.1001/jama.2018.3024. JAMA. 2018. PMID: 29677303 Free PMC article. Review.
Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.
Zaccardi F, Dhalwani NN, Dales J, Mani H, Khunti K, Davies MJ, Webb DR. Zaccardi F, et al. Diabetes Obes Metab. 2018 Apr;20(4):985-997. doi: 10.1111/dom.13185. Epub 2018 Jan 8. Diabetes Obes Metab. 2018. PMID: 29205774
Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.
Kramer CK, Ye C, Campbell S, Retnakaran R. Kramer CK, et al. JACC Heart Fail. 2018 Oct;6(10):823-830. doi: 10.1016/j.jchf.2018.05.021. Epub 2018 Sep 5. JACC Heart Fail. 2018. PMID: 30196071 Free article.
Cardiovascular outcomes in trials of new antidiabetic drug classes: a network meta-analysis.
Fei Y, Tsoi MF, Cheung BMY. Fei Y, et al. Cardiovasc Diabetol. 2019 Aug 28;18(1):112. doi: 10.1186/s12933-019-0916-z. Cardiovasc Diabetol. 2019. PMID: 31462224 Free PMC article.
Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.
Hussein H, Zaccardi F, Khunti K, Davies MJ, Patsko E, Dhalwani NN, Kloecker DE, Ioannidou E, Gray LJ. Hussein H, et al. Diabetes Obes Metab. 2020 Jul;22(7):1035-1046. doi: 10.1111/dom.14008. Epub 2020 Mar 18. Diabetes Obes Metab. 2020. PMID: 32077218 Review.
Acute Kidney Injury Events in Patients With Type 2 Diabetes Using SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs: A Retrospective Cohort Study.
Rampersad C, Kraut E, Whitlock RH, Komenda P, Woo V, Rigatto C, Tangri N. Rampersad C, et al. Am J Kidney Dis. 2020 Oct;76(4):471-479.e1. doi: 10.1053/j.ajkd.2020.03.019. Epub 2020 May 25. Am J Kidney Dis. 2020. PMID: 32464161
Myocardial infarction in type 2 diabetes using sodium-glucose co-transporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors or glucagon-like peptide-1 receptor agonists: proportional hazards analysis by deep neural network based machine learning.
Yamada T, Iwasaki K, Maedera S, Ito K, Takeshima T, Noma H, Shojima N. Yamada T, et al. Curr Med Res Opin. 2020 Mar;36(3):403-409. doi: 10.1080/03007995.2019.1706043. Epub 2020 Jan 6. Curr Med Res Opin. 2020. PMID: 31855074
98 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback